A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.
Clinical trial NCT05627362 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05627362
- Sponsor
- Ipsen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-29
- Primary completion
- 2031-09-23
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.